Drug Safety Journals List
Drug Safety is meant for covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management. Drug Safety's structured program of peer-reviewed invited
articles ensure comprehensive and important coverage of all topics. The drug focuses on definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual
drugs and drug classes. Benefit-risk assessments provide an in-depth review of adverse effect and efficacy data for a drug in a defined therapeutic area. High-quality original research that specialize in the clinical implications of drug treatment questions of safety is additionally published. "Current drug safety" is "Curr. Drug Saf.".
Pharmacovigilance has its own unique terminology that's important to know . Most of the subsequent terms are used within this text and are peculiar to drug safety, although some are employed by other disciplines within the
pharmaceutical sciences also .Adverse drug reaction may be a side effect (non intended reaction to the drug) occurring with a drug where a positive (direct) causal relationship between the event and therefore the drug is assumed , or has been proven, to exist.Adverse event (AE) may be a side effect occurring with a drug. By definition, the causal relationship between the AE and therefore the drug is unknown. Benefits are commonly expressed because the proven therapeutic good of a product but should also include the patient's subjective assessment of its effects.
High Impact List of Articles
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Inflammasome activation markers are independently associated with hypoalphalipoproteinemia in a Mexican-Mestizo population
Aida Medina-Urrutia, Carlos Posadas-Romero, Esteban Jorge-Galarza, Angel R Lopez-Uribe, del Carmen Gonzalez-Salazara and Juan G Juarez-Rojas
Research Article: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Clinical trial recruitment in the information age
Tom Dorsett, Stella Bennett
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
Relevant Topics in Clinical